Showing results (691-700 of 801) with videos related to

Sort By:
Pageof 81
European Thyroid Journal|March 29, 2021
Quality of Life during Treatment with Lenvatinib for Thyroid Cancer: The Patients' Perspective beyond the Medical EvaluationAlice Nervo, Alberto Ragni, Alessandro Piovesan, et al.
European Thyroid Journal|March 29, 2021
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM StudyLaura Moss, Catrin Cox, Jonathan Wadsley, et al.
European Thyroid Journal|March 29, 2021
Therapeutic Plasma Exchange in Refractory HyperthyroidismClotilde Saïe, Cécile Ghander, Samir Saheb, et al.
European Thyroid Journal|September 20, 2022
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancerLuciana Puleo, Laura Agate, Irene Bargellini, et al.
European Thyroid Journal|September 2, 2022
Consumptive hypothyroidism in a patient with malignant rhabdoid tumor of the kidney: case report on a newly found associationRoberto Fiore, Stefano La Rosa, Silvia Uccella, et al.
European Thyroid Journal|November 22, 2023
Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology resultsAglaia Kyrilli, Nunzia Tacelli, Lucia Russo, et al.
European Thyroid Journal|January 18, 2024
Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameterHaitao Zhang, Hao Hu, Yueyue Wang, et al.
European Thyroid Journal|January 8, 2024
Real-world clinical profile, RET mutation testing, treatments, and PROs for MTC in EuropeGrace Segall, Ravinder Singh, Min-Hua Jen, et al.
European Thyroid Journal|January 12, 2024
Selenium supplementation and placebo are equally effective in improving quality of life in patients with hypothyroidismCamilla Larsen, Kristian Hillert Winther, Per Karkov Cramon, et al.
European Thyroid Journal|December 14, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancerAndrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, et al.
Pageof 81